1. Home
  2. LXFR vs EOLS Comparison

LXFR vs EOLS Comparison

Compare LXFR & EOLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Luxfer Holdings PLC

LXFR

Luxfer Holdings PLC

HOLD

Current Price

$17.23

Market Cap

459.5M

Sector

Industrials

ML Signal

HOLD

Logo Evolus Inc.

EOLS

Evolus Inc.

SELL

Current Price

$7.80

Market Cap

529.1M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
LXFR
EOLS
Founded
1898
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
459.5M
529.1M
IPO Year
2002
2018

Fundamental Metrics

Financial Performance
Metric
LXFR
EOLS
Price
$17.23
$7.80
Analyst Decision
Buy
Analyst Count
0
6
Target Price
N/A
★ $15.00
AVG Volume (30 Days)
390.0K
★ 601.9K
Earning Date
10-27-2026
11-04-2026
Dividend Yield
★ 3.02%
N/A
EPS Growth
N/A
★ 1.23
EPS
★ 0.31
N/A
Revenue
★ $384,600,000.00
$297,176,000.00
Revenue This Year
N/A
$12.44
Revenue Next Year
$6.26
$17.37
P/E Ratio
$55.63
★ N/A
Revenue Growth
N/A
★ 11.61
52 Week Low
$11.26
$3.86
52 Week High
$19.45
$9.31

Technical Indicators

Market Signals
Indicator
LXFR
EOLS
Relative Strength Index (RSI) 52.14 44.69
Support Level $17.19 $7.59
Resistance Level $17.38 $8.47
Average True Range (ATR) 0.05 0.31
MACD -0.01 -0.06
Stochastic Oscillator 31.32 43.40

Price Performance

Historical Comparison
LXFR
EOLS

About LXFR Luxfer Holdings PLC

Luxfer Holdings PLC is engaged in materials engineering and the manufacture of materials, components, and gas containment products. The company has two reportable segments: Elektron and Gas Cylinders. The Elektron segment produces specialty materials based on magnesium and zirconium for applications in aerospace, defense, automotive, and industrial markets. The Gas Cylinders segment manufactures high-pressure gas containment products using aluminum alloys and carbon composite technologies for use in healthcare, emergency response, aerospace, and alternative fuel transportation markets.

About EOLS Evolus Inc.

Evolus Inc is a performance beauty company offering medical aesthetic products in the cash-pay aesthetic market. The company's commercially available products represent two product categories within medical aesthetics: injectable neurotoxins and injectable hyaluronic acid (HA) gels. Its commercial products are: Jeuveau, a proprietary 900-kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe frown lines, in adults; and Evolysse, a collection of injectable HA gels that utilizes first-generation cold technology. The line includes several products, including mid face, nasolabial folds, lips, and eyes. Geographically, the company currently has operations in the United States, Canada, Europe, and Australia.

Share on Social Networks: